GlassScriptPhysician profile
Julian Lichter
NPI 1215957527
$1,865.73
in general payments reported to CMS, 2019-2025
22 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $392 · 2021: $253 · 2022: $286 · 2023: $41.92 · 2024: $29.07 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $430.25 | 2019-2021 | |
| Angiodynamics, INC. | $298.57 | 2025 | Alphavac |
| Inari Medical, INC. | $236.29 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Glaxosmithkline, LLC. | $221.48 | 2019-2021 | |
| Penumbra, INC. | $120.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $118.16 | 2019-2021 | |
| Insmed, INC. | $79.12 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $59.27 | 2025 | Arctic Sun 5000 |
| Pulmonx Corporation | $51.47 | 2020 | |
| Allergan, INC. | $40.82 | 2019 | |
| Advanced Respiratory, INC | $26.83 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.45 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.51 | 2019 | |
| Merck Sharp & Dohme LLC | $19.39 | 2019 | |
| Pfizer INC. | $19.28 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.92 | 2019 | |
| Getinge USA Sales, LLC | $18.44 | 2025 | Cardiosave Rescue |
| Genzyme Corporation | $15.07 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.11 | 2019 | |
| Circassia INC. | $12.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.12 | 2020 | |
| Electromed, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julian Lichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.